Micro8

Curated by Signal

Hemophilia treatment monitoring application

Overview

Micro8 is a hemophilia treatment monitoring application that was co-developed by Biogen and Microhealth, as a companion for Biogen's hemophilia drug Eloctate. Patients can view and receive reminders for drug infusion as well as enter information about bleeding issues and their infusion schedules. All the information is viewable by their healthcare provider, who can then use it to adjust treatment regimens.

Key facts

Founded: 2014
Headquarters: Cambridge, United States
Stage: Sign up to view
Industry: Health Technology

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Global CCM
Platform offering patient monitoring solutions
Health TechnologyGreat Neck, United States
Patient Safety
Developer of sleep and oximetry monitoring devices
Health TechnologyColumbus, United States
DocuTAP
EHR, Practice Management and RCM solutions for urgent care practices
Health TechnologySioux Falls, United States

About Micro8

What does Micro8 do?

Micro8 is a hemophilia treatment monitoring application that was co-developed by Biogen and Microhealth, as a companion for Biogen's hemophilia drug Eloctate.

Where is Micro8 headquartered?

Micro8 is headquartered in Cambridge, United States.

When was Micro8 founded?

Micro8 was founded in 2014.

Which sector is Micro8 in?

Micro8 operates in Health Technology.

Who are Micro8's competitors?

Companies similar to Micro8 include Global CCM, Patient Safety, and DocuTAP.